Literature DB >> 18638603

Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia.

Hussain Isma'eel1, Abdul Hamid El Chafic, Fuad El Rassi, Adlette Inati, Susan Koussa, Rose Daher, Walid Gharzuddin, Samir Alam, Ali Taher.   

Abstract

Cardiovascular impairment is a major cause of morbidity and mortality in patients with thalassemia intermedia. In this study, echocardiographic assessment of left heart condition was performed in patients with thalassemia intermedia, and its relation to hematologic variables--amino terminal pro-brain natriuretic peptide (NT-proBNP), ferritin, hemoglobin--and liver iron concentration (LIC) was investigated. Echocardiographic assessment was performed using pulse-wave Doppler and tissue Doppler imaging. Data from 74 patients with thalassemia intermedia--35 men, 39 women, mean age 26.5 years (8 to 63)--were randomly selected and evaluated. Blood samples were collected for NT-proBNP levels in a random subgroup of 19 patients. Mean baseline values were hemoglobin 8.4 g/dl (4.9 to 13.1), serum ferritin 902.6 ng/ml (15 to 4,140), LIC 9.0 mg Fe/g (0.5 to 32.1), and NT-proBNP 113.5 pg/ml (16.4 to 371). Correlation between LIC and pulmonary artery systolic pressure was significant, suggesting that iron loading in the liver is indicative of cardiovascular sequelae. NT-proBNP was significantly correlated with the ratio of the left ventricular early rapid filling wave to early diastolic velocity at the mitral annulus (r = 0.50, p = 0.04) and hemoglobin (r = -0.49, p = 0.03), but not with other characteristics assessed. In conclusion, this study has highlighted the importance of using tissue Doppler imaging rather than pulse-wave Doppler to characterize left ventricular diastolic dysfunction in patients with thalassemia intermedia. Demonstration of the correlation of LIC and pulmonary artery systolic pressure independent of left ventricular filling pressures supports our hypothesis that left ventricular diastolic dysfunction does not contribute to the increased pulmonary artery systolic pressure in patients with thalassemia intermedia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18638603     DOI: 10.1016/j.amjcard.2008.03.066

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Prepubertal Hypertransfusion in Thalassemia Intermedia: A Case Report of Sustained Positive Effects on Growth, Splenic Function and Endocrine Parameters.

Authors:  Surekha Tony; Shahina Daar; Mathew Zachariah; Yasser Wali
Journal:  Oman Med J       Date:  2012-11

Review 3.  N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin.

Authors:  Eva Welisch; Kambiz Norozi; Ralf Rauch
Journal:  Clin Res Cardiol       Date:  2011-04-14       Impact factor: 5.460

4.  Early echocardiographic findings in β-thalassemia intermedia patients using standard and tissue Doppler methods.

Authors:  Hamid Amoozgar; Nahal Farhani; Mehran Karimi
Journal:  Pediatr Cardiol       Date:  2010-11-17       Impact factor: 1.655

5.  Screening for cardiomyopathy in muscular dystrophy with tissue doppler imaging.

Authors:  Rachna Seth; Sandeep Seth; Veena Kalra
Journal:  Indian J Pediatr       Date:  2010-04-17       Impact factor: 1.967

6.  Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia.

Authors:  Roya Isa Tafreshi; Mohammad Radgoodarzi; Kadijeh Arjmandi Rafsanjani; Fahimeh Soheilipour
Journal:  Front Pediatr       Date:  2022-06-17       Impact factor: 3.569

7.  Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.

Authors:  Nihal Bakeer; Jeanne James; Swarnava Roy; Janaka Wansapura; Shiva Kumar Shanmukhappa; John N Lorenz; Hanna Osinska; Kurt Backer; Anne-Cecile Huby; Archana Shrestha; Omar Niss; Robert Fleck; Charles T Quinn; Michael D Taylor; Enkhsaikhan Purevjav; Bruce J Aronow; Jeffrey A Towbin; Punam Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

8.  A Comparison Between MRIT2 and NT-ProBNP in Early Detection of Heart Diseases in Thalassemia Major Patients: A Cross-Sectional Study.

Authors:  Kourosh Goudarzipour; Parinaz Alizadeh; Hesameddin Hoseini Tavassol; Reyhaneh Kazemi; Peyman Eshghi; Saeed Mojtahedzadeh
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-27       Impact factor: 0.900

9.  Thalassaemia intermedia: an update.

Authors:  Ali T Taher; Khaled M Musallam; Maria D Cappellini
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-08-29       Impact factor: 2.576

10.  Comparison of right and left side heart functions in patients with thalassemia major, patients with thalassemia intermedia, and control group.

Authors:  Noormohammad Noori; Mehdi Mohamadi; Kambiz Keshavarz; Seyed Mostafa Alavi; Maziar Mahjoubifard; Yalda Mirmesdagh
Journal:  J Tehran Heart Cent       Date:  2013-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.